StockData
Sagimet Biosciences Inc. logo

Sagimet Biosciences Inc. (SGMT) income statement

SGMTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$9.08−0.54 (-5.61%)

Close on Nov 20, 2026Market cap $564.40MP/E –Yield –

See a number that looks wrong?